Shin Yoshimura, Kentaro Kawano, Ryusuke Matsumura, Narumi Sugihara, Koji Furuno
Index: J. Biomed. Biotechnol. 2009 , 467489, (2009)
Full Text: HTML
N-acetyl 5-aminosalicylic acid (5-AcASA) that was intracellularly formed from 5-aminosalicylic acid (5-ASA) at 200 microM was discharged 5.3, 7.1, and 8.1-fold higher into the apical site than into the basolateral site during 1, 2, and 4-hour incubations, respectively, in Caco-2 cells grown in Transwells. The addition of flavonols (100 microM) such as fisetin and quercetin with 5-ASA remarkably decreased the apically directed efflux of 5-AcASA. When 5-ASA (200 microM) was added to Caco-2 cells grown in tissue culture dishes, the formation of 5-AcASA decreased, and, in addition, the formed 5-AcASA was found to be accumulated within the cells in the presence of such flavonols. Thus, the decrease in 5-AcASA efflux by such flavonols was attributed not only to the inhibition of N-acetyl-conjugation of 5-ASA but to the predominant cellular accumulation of 5-AcASA. Various flavonoids also had both of the effects with potencies that depend on their specific structures. The essential structure of flavonoids was an absence of a hydroxyl substitution at the C5 position on the A-ring of flavone structure for the inhibitory effect on the N-acetyl-conjugation of 5-ASA, and a presence of hydroxyl substitutions at the C3' or C4' position on the B-ring of flavone structure for the promoting effect on the cellular accumulation of 5-AcASA. Both the decrease in 5-AcASA apical efflux and the increase in 5-AcASA cellular accumulation were also caused by MK571 and indomethacin, inhibitors of MRPs, but not by quinidine, cyclosporin A, P-glycoprotein inhibitors, and mitoxantrone, a BCRP substrate. These results suggest that certain flavonoids suppress the apical efflux of 5-AcASA possibly by inhibiting MRPs pumps located on apical membranes in Caco-2 cells.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
N-Acetyl Mesalazine
CAS:51-59-2 |
C9H9NO4 |
Simultaneous determination of 5-aminosalicylic acid, acetyl-...
1995-12-01 [J. Pharm. Biomed. Anal. 14(1-2) , 175-80, (1995)] |
Safety, efficacy, and pharmacokinetics of balsalazide in ped...
2009-11-01 [J. Pediatr. Gastroenterol. Nutr. 49(5) , 571-9, (2009)] |
Radical-derived oxidation products of 5-aminosalicylic acid ...
1994-11-04 [J. Chromatogr. B, Biomed. Appl. 661(1) , 57-68, (1994)] |
Superoxide inhibition following different stimuli of respira...
1994-01-01 [Dig. Dis. Sci. 39(1) , 145-51, (1994)] |
Pharmacokinetic studies of benzalazine.
1994-12-01 [Arzneimittelforschung 44(12) , 1381-3, (1994)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved